Log in | Register

Sodium lactate versus mannitol in the treatment of intracranial hypertensive episodes in severe traumatic brain-injured patients

Carole Ichai| Guy Armando| Jean-Christophe Orban| Frederic Berthier| Laurent Rami| Corine Samat-Long| Dominique Grimaud| Xavier Leverve
Original
Volume 35, Issue 3 / March , 2009

Pages 471 - 479

Abstract

Objectives

Traumatic brain injury (TBI) is still a major cause of mortality and morbidity. Recent trials have failed to demonstrate a beneficial outcome from therapeutic treatments such as corticosteroids, hypothermia and hypertonic saline. We investigated the effect of a new hyperosmolar solution based on sodium lactate in controlling raised intracranial pressure (ICP).

Design and setting

Prospective open randomized study in an adult ICU.

Patients

Thirty-four patients with isolated severe TBI (Glasgow Coma Scale ≤ 8) and intracranial hypertension were allocated to receive equally hyperosmolar and isovolumic therapy, consisting of either mannitol or sodium lactate. Rescue therapy by crossover to the alternative treatment was indicated when ICP could not be controlled. The primary endpoint was efficacy in lowering ICP after 4 h, with a secondary endpoint of the percentage of successfully treated episodes of intracranial hypertension. The analysis was performed with both intention-to-treat and actual treatments provided.

Measurements and results

Compared to mannitol, the effect of the lactate solution on ICP was significantly more pronounced (7 vs. 4 mmHg, P = 0.016), more prolonged (fourth-hour-ICP decrease: −5.9 ± 1 vs. −3.2 ± 0.9 mmHg, P = 0.009) and more frequently successful (90.4 vs. 70.4%, P = 0.053).

Conclusion

Acute infusion of a sodium lactate-based hyperosmolar solution is effective in treating intracranial hypertension following traumatic brain injury. This effect is significantly more pronounced than that of an equivalent osmotic load of mannitol. Additionally, in this specific group of patients, long-term outcome was better in terms of GOS in those receiving as compared to mannitol. Larger trials are warranted to confirm our findings.

Keywords

References

  1. Bulger EM, Nathens AB, Rivara FP, Moore M, MacKenzie EJ, Jurkovich GJ (2002) Management of severe head injury: institutional variations in care and effect on outcome. Crit Care Med 30:1870–1876
    • View reference on PubMed
    • View reference on publisher's website
  2. Jiang JY, Gao GY, Li WP, Yu MK, Zhu C (2002) Early indicators of prognosis in 846 cases of severe traumatic brain injury. J Neurotrauma 19:869–874
    • View reference on PubMed
    • View reference on publisher's website
  3. Stocchetti N, Penny KI, Dearden M, Braakman R, Cohadon F, Iannotti F, Lapierre F, Karimi A, Maas A Jr, Murray GD, Ohman J, Persson L, Servadei F, Teasdale GM, Trojanowski T, Unterberg A (2001) Intensive care management of head-injured patients in Europe: a survey from the European brain injury consortium. Intensive Care Med 27:400–406
  4. Stocchetti N, Rossi S, Buzzi F, Mattioli C, Paparella A, Colombo A (1999) Intracranial hypertension in head injury: management and results. Intensive Care Med 25:371–376
  5. Cooper DJ, Myles PS, McDermott FT, Murray LJ, Laidlaw J, Cooper G, Tremayne AB, Bernard SS, Ponsford J (2004) Prehospital hypertonic saline resuscitation of patients with hypotension and severe traumatic brain injury: a randomized controlled trial. Jama 291:1350–1357
    • View reference on PubMed
    • View reference on publisher's website
  6. Roberts I, Yates D, Sandercock P, Farrell B, Wasserberg J, Lomas G, Cottingham R, Svoboda P, Brayley N, Mazairac G, Laloe V, Munoz-Sanchez A, Arango M, Hartzenberg B, Khamis H, Yutthakasemsunt S, Komolafe E, Olldashi F, Yadav Y, Murillo-Cabezas F, Shakur H, Edwards P (2004) Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet 364:1321–1328
    • View reference on PubMed
    • View reference on publisher's website
  7. Clifton GL, Miller ER, Choi SC, Levin HS, McCauley S, Smith KR Jr, Muizelaar JP, Wagner FC Jr, Marion DW, Luerssen TG, Chesnut RM, Schwartz M (2001) Lack of effect of induction of hypothermia after acute brain injury. N Engl J Med 344:556–563
    • View reference on PubMed
    • View reference on publisher's website
  8. Polderman KH, Tjong Tjin Joe R, Peerdeman SM, Vandertop WP, Girbes AR (2002) Effects of therapeutic hypothermia on intracranial pressure and outcome in patients with severe head injury. Intensive Care Med 28:1563–1573
  9. Qiu W, Zhang Y, Sheng H, Zhang J, Wang W, Liu W, Chen K, Zhou J, Xu Z (2007) Effects of therapeutic mild hypothermia on patients with severe traumatic brain injury after craniotomy. J Crit Care 22:229–235
    • View reference on PubMed
    • View reference on publisher's website
  10. Schierhout G, Roberts I (2000) Mannitol for acute traumatic brain injury. Cochrane Database Syst Rev CD001049
  11. Marik PE, Varon J, Trask T (2002) Management of head trauma. Chest 122:699–711
    • View reference on PubMed
    • View reference on publisher's website
  12. Francony G, Fauvage B, Falcon D, Canet C, Dilou H, Lavagne P, Jacquot C, Payen JF (2008) Equimolar doses of mannitol and hypertonic saline in the treatment of increased intracranial pressure. Crit Care Med 36(3):795–800
  13. Schwartz ML, Tator CH, Rowed DW, Reid SR, Meguro K, Andrews DF (1984) The University of Toronto head injury treatment study: a prospective, randomized comparison of pentobarbital and mannitol. Can J Neurol Sci 11:434–440
    • View reference on PubMed
  14. Sorani MD, Manley GT (2008) Dose-response relationship of mannitol and intracranial pressure: a metaanalysis. J Neurosurg 108:80–87
    • View reference on PubMed
    • View reference on publisher's website
  15. McManus ML, Soriano SG (1998) Rebound swelling of astroglial cells exposed to hypertonic mannitol. Anesthesiology 88:1586–1591
    • View reference on PubMed
    • View reference on publisher's website
  16. Mendelow AD, Teasdale GM, Russell T, Flood J, Patterson J, Murray GD (1985) Effect of mannitol on cerebral blood flow and cerebral perfusion pressure in human head injury. J Neurosurg 63:43–48
    • View reference on PubMed
  17. Paczynski RP (1997) Osmotherapy. Basic concepts and controversies. Crit Care Clin 13:105–129
    • View reference on PubMed
    • View reference on publisher's website
  18. Berger S, Schurer L, Hartl R, Deisbock T, Dautermann C, Murr R, Messmer K, Baethmann A (1994) 7.2% NaCl/10% dextran 60 versus 20% mannitol for treatment of intracranial hypertension. Acta Neurochir Suppl (Wien) 60:494–498
  19. Doyle JA, Davis DP, Hoyt DB (2001) The use of hypertonic saline in the treatment of traumatic brain injury. J Trauma 50:367–383
    • View reference on PubMed
    • View reference on publisher's website
  20. Qureshi AI, Suarez JI, Bhardwaj A, Mirski M, Schnitzer MS, Hanley DF, Ulatowski JA (1998) Use of hypertonic (3%) saline/acetate infusion in the treatment of cerebral edema: Effect on intracranial pressure and lateral displacement of the brain. Crit Care Med 26:440–446
    • View reference on PubMed
    • View reference on publisher's website
  21. Battison C, Andrews PJ, Graham C, Petty T (2005) Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranial pressure after brain injury. Crit Care Med 33:196–202 (discussion 257–198)
  22. Schurr A (2002) Lactate, glucose and energy metabolism in the ischemic brain (Review). Int J Mol Med 10:131–136
    • View reference on PubMed
  23. Schurr A, Payne RS, Miller JJ, Rigor BM (1997) Brain lactate is an obligatory aerobic energy substrate for functional recovery after hypoxia: further in vitro validation. J Neurochem 69:423–426
    • View reference on PubMed
  24. Maran A, Cranston I, Lomas J, Macdonald I, Amiel SA (1994) Protection by lactate of cerebral function during hypoglycaemia. Lancet 343:16–20
    • View reference on PubMed
    • View reference on publisher's website
  25. King P, Kong MF, Parkin H, MacDonald IA, Barber C, Tattersall RB (1998) Intravenous lactate prevents cerebral dysfunction during hypoglycaemia in insulin-dependent diabetes mellitus. Clin Sci (Lond) 94:157–163
  26. Schurr A, Payne RS, Miller JJ, Tseng MT (2001) Preischemic hyperglycemia-aggravated damage: evidence that lactate utilization is beneficial and glucose-induced corticosterone release is detrimental. J Neurosci Res 66:782–789
    • View reference on PubMed
    • View reference on publisher's website
  27. Rice AC, Zsoldos R, Chen T, Wilson MS, Alessandri B, Hamm RJ, Bullock MR (2002) Lactate administration attenuates cognitive deficits following traumatic brain injury. Brain Res 928:156–159
    • View reference on PubMed
    • View reference on publisher's website
  28. Holloway R, Zhou Z, Harvey HB, Levasseur JE, Rice AC, Sun D, Hamm RJ, Bullock MR (2007) Effect of lactate therapy upon cognitive deficits after traumatic brain injury in the rat. Acta Neurochir (Wien) 149:919–927 (discussion 927)
  29. Shackford SR, Schmoker JD, Zhuang J (1994) The effect of hypertonic resuscitation on pial arteriolar tone after brain injury and shock. J Trauma 37:899–908
    • View reference on PubMed
  30. Shackford SR, Zhuang J, Schmoker J (1992) Intravenous fluid tonicity: effect on intracranial pressure, cerebral blood flow, and cerebral oxygen delivery in focal brain injury. J Neurosurg 76:91–98
    • View reference on PubMed
  31. Jennett B, Bond M (1975) Assessment of outcome after severe brain damage. Lancet 1:480–484
    • View reference on PubMed
    • View reference on publisher's website
  32. Marshall LF, Marshall SB, Klauber MR, Van Berkum Clark M, Eisenberg H, Jane JA, Luerssen TG, Marmarou A, Foulkes MA (1992) The diagnosis of head injury requires a classification based on computed axial tomography. J Neurotrauma 9 Suppl 1:S287–S292
    • View reference on PubMed
  33. Marmarou A (1994) Traumatic brain edema: an overview. Acta Neurochir Suppl (Wien) 60:421–424
  34. Stocchetti N (2001) Risk prevention, avoidable deaths and mortality-morbidity reduction in head injury. Eur J Emerg Med 8:215–219
    • View reference on PubMed
    • View reference on publisher's website
  35. Van den Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ (2005) Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 64:1348–1353
    • View reference on PubMed
  36. Chiolero R, Tappy L, Gillet M, Revelly JP, Roth H, Cayeux C, Schneiter P, Leverve X (1999) Effect of major hepatectomy on glucose and lactate metabolism. Ann Surg 229:505–513
    • View reference on PubMed
    • View reference on publisher's website
  37. Mustafa I, Roth H, Hanafiah A, Hakim T, Anwar M, Siregar E, Leverve XM (2003) Effect of cardiopulmonary bypass on lactate metabolism. Intensive Care Med 29:1279–1285
  38. Mustafa I, Leverve XM (2002) Metabolic and hemodynamic effects of hypertonic solutions: sodium-lactate versus sodium chloride infusion in postoperative patients. Shock 18:306–310
    • View reference on PubMed
    • View reference on publisher's website
  39. Stocchetti N, Maas AI, Chieregato A, van der Plas AA (2005) Hyperventilation in head injury: a review. Chest 127:1812–1827
    • View reference on PubMed
    • View reference on publisher's website
  40. Halestrap AP, Price NT (1999) The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem J 343 Pt 2:281–299
    • View reference on PubMed
    • View reference on publisher's website
  41. Chen H, Sun D (2005) The role of Na-K-Cl co-transporter in cerebral ischemia. Neurol Res 27:280–286
    • View reference on PubMed
    • View reference on publisher's website
  42. Cater HL, Benham CD, Sundstrom LE (2001) Neuroprotective role of monocarboxylate transport during glucose deprivation in slice cultures of rat hippocampus. J Physiol 531:459–466
    • View reference on PubMed
    • View reference on publisher's website
  43. Schurr A (2006) Lactate: the ultimate cerebral oxidative energy substrate? J Cereb Blood Flow Metab 26:142–152
    • View reference on PubMed
    • View reference on publisher's website
  44. Pellerin L, Bergersen LH, Halestrap AP, Pierre K (2005) Cellular and subcellular distribution of monocarboxylate transporters in cultured brain cells and in the adult brain. J Neurosci Res 79:55–64
    • View reference on PubMed
    • View reference on publisher's website

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement